FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085452 [Registered on: 23/04/2025] Trial Registered Prospectively
Last Modified On: 23/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Other 
Public Title of Study   To investigate the effectiveness of individualized homeopathic remedies for chronic paranasal sinusitis, a study utilizing the Synthesis Repertory 
Scientific Title of Study   To study the efficacy of individualised homoeopathic remedy in cases of chronic paranasal sinusitis with the help of synthesis repertory 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR SHUBHRA YADAV 
Designation  M.D. Homoeopathic Repertory Postgraduate Student 
Affiliation  Ahmedabad Homoeopathic Medical College and Sainath Hospital 
Address  Department of Homeopathic Repertory, Ahmedabad Homoeopathic Medical College, Sainath Hospital, Opposite Kabir Enclave, Bopal Ghuma Road, Ghuma, Ahmedabad - 380058

Ahmadabad
GUJARAT
380058
India 
Phone  9586844770  
Fax    
Email  2204072030005@paruluniversity.ac.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Devangi G Pandya  
Designation  Professor and Postgraduate Guide of Homoeopathic Repertory 
Affiliation  Ahmedabad Homoeopathic Medical College and Sainath Hospital 
Address  Department of Homeopathic Repertory, Ahmedabad Homoeopathic Medical College, Sainath Hospital, Opposite Kabir Enclave, Bopal Ghuma Road, Ghuma, Ahmedabad

Ahmadabad
GUJARAT
380058
India 
Phone  7600399549  
Fax    
Email  devangi.pandyaahmc@paruluniversity.ac.in  
 
Details of Contact Person
Public Query
 
Name  DR SHUBHRA YADAV 
Designation  M.D. Homoeopathic Repertory Postgraduate Student 
Affiliation  Ahmedabad Homoeopathic Medical College and Sainath Hospital 
Address  Department of Homeopathic Repertory, Ahmedabad Homoeopathic Medical College, Sainath Hospital, Opposite Kabir Enclave, Bopal Ghuma Road, Ghuma, Ahmedabad - 380058

Ahmadabad
GUJARAT
380058
India 
Phone  9586844770  
Fax    
Email  2204072030005@paruluniversity.ac.in  
 
Source of Monetary or Material Support  
Ahmedabad Homoeopathic Medical College and Sainath Hospital. Parul University, Opposite Kabir Enclave, Bopal Ghuma Road, Ghuma, Ahmedabad - 380058  
 
Primary Sponsor  
Name  DR SHUBHRA YADAV 
Address  M.D. Homoeopathic Repertory Postgraduate Student, Department of Homoeopathic Repertory, Ahmedabad Homoeopathic Medical College and Sainath Hospital. Opposite Kabir Enclave, Bopal Ghuma Road, Ghuma, Ahmedabad - 380058 
Type of Sponsor  Other [The principal investigator] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SHUBHRA YADAV  Ahmedabad Homoeopathic Medical College and Sainath Hospital  Sainath Hospital, Medicine and Pediatrics division, Department of Homoeopathic Repertory.
Ahmadabad
GUJARAT 
9586844770

2204072030005@paruluniversity.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee for Human Research-Sainath Hospital, Ahmedabad (IECHR-Sainath Hospital)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J329||Chronic sinusitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homoeopathic Medicine  After case taking and totality of the symptoms formed. It is planned as administering indicated homeopathic remedies in centesimal potencies, as decided appropriate to the case or condition after case taking and repertorization utilizing either manual or computer repertorization. Each dose shall consist of 4 globules (no. 30) of cane sugar, medicated with the indicated homoeopathic medicine, to be taken orally on clean tongue with empty stomach; dosage and repetition as per the individual requirements of each case. Route of administration : Oral. Duration: Till the status of the patient changed as mentioned in the secondary outcome.  
Comparator Agent  Individualized Homoeopathic Medicine  After case taking and totality of the symptoms formed. It is planned as administering indicated homeopathic remedies in centesimal potencies, as decided appropriate to the case or condition after case taking and repertorization utilizing either manual or computer repertorization. Each dose shall consist of 4 globules (no. 30) of cane sugar, medicated with the indicated homoeopathic medicine, to be taken orally on clean tongue with empty stomach; dosage and repetition as per the individual requirements of each case. Route of administration : Oral. Duration: Till the status of the patient changed as mentioned in the secondary outcome. 
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  All socioeconomic status
Pre-diagnosed cases of chronic paranasal sinusitis
Nasal Symptom Questionnaire Scale more than or equal to 10 
 
ExclusionCriteria 
Details  Previous sinus surgery
Cases associated with gross pathological changes
Pregnancy 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Nasal symptom questionnaire scale  At the beginning before starting the treatment and at the follow up - every 07 to 15 days or as per the requirements. 
 
Secondary Outcome  
Outcome  TimePoints 
Nasal symptoms questionnaire scale for the relief of symptoms of nasal obstruction and rhinorrhoea as well as the presence or absence of systemic signs and symptoms utilizing three criteria:
Marked improvement: Characterized by a marked decrease in the intensity and frequency of presenting complaints, accompanied by an overall sense of well-being.
Moderate improvement: Indicates a substantial response with a notable decrease in the majority of symptoms.
Status Quo: No discernible increase or decrease in the symptoms of the patients. 
During follow-up for each case at regular interval of 7-15 days or as per specific requirements. 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [2204072030005@paruluniversity.ac.in].

  6. For how long will this data be available start date provided 10-05-2025 and end date provided 30-06-2026?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   This study is randomized, participant blinded, single center trial to study the efficacy of the individualized homoeopathic medicine with synthesis repertory in the treatment of chronic paranasal sinusitis. In this study participants will be recruited as mentioned in inclusion and exclusion criteria. The case taking process will adhere to the guidelines outlined by Dr. Hahnemann in aphorism 83-104. Following a thorough analysis and evaluation of the case symptoms, the totality of symptoms will be formulated. Medicine selection will be performed from the Synthesis repertory based on the totality of symptoms, utilizing either manual or computer repertorization. As an assessment tool Nasal Symptom Questionnaire Scale will be used. Various potencies of the selected medicines will be administered as per the individual requirements of each case. Follow up of each case will be taken at the interval of 7 to 15 days or as per the requirement. Primary and secondary outcomes will be measured as mentioned earlier. 
Close